𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characteristic antitumor activity of cytarabine ocfosfate against human colorectal adenocarcinoma xenografts in nude mice

✍ Scribed by Kunihiko Koga, Eri Iizuka, Akira Sato…

Book ID
120776371
Publisher
Springer
Year
1995
Tongue
English
Weight
321 KB
Volume
36
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor activity of paclitaxel against
Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice
✍ Kubota, Tetsuro; Matsuzaki, Shinjiro Wilson; Hoshiya, Yasunori; Watanabe, Masahi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Background: Paclitaxel (BMS-181339: Taxol) is a promising agent against previously treated breast cancer. The antitumor activity of paclitaxel was evaluated using five human breast carcinoma xenografts in nude mice. Methods: Paclitaxel at 20 mg/kg dissolved in 0.2 ml ethanol/cremophor EL solution wa

Antitumor effect of triphenylethylene de
Antitumor effect of triphenylethylene derivative (TAT-59) against human breast carcinoma xenografts in nude mice
✍ Dr. Jun-Ichi Koh; Tetsuro Kubota; Fumiki Asanuma; Yoshinori Yamada; Eiji Kawamur 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

## Abstract The antitumor activity of a newly synthesized triphenylethylene derivative {(E)‐4‐[1‐4‐[2‐(dimethylamino)ethoxy‐phenyl]‐2‐(4‐isopropyl)phenyl‐1‐butenyl] phenyl monophosphate} (TAT‐59) was investigated against human breast carcinoma xenografts in nude mice with reference to the changes o

Synergistic antitumor activity of combin
Synergistic antitumor activity of combination chemotherapy with mitomycin C and cisplatin against human gastric cancer xenografts in nude mice
✍ Yoshiro Saikawa; Dr. Tetsuro Kubota; Tsong-Hong Kuo; Toshiharu Furukawa; Suguru 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

A new combined cancer chemotherapy regimen of mitomycin C (MMC) and cisplatin (DDP) showed synergistic antitumor activity against human gastric cancer xenografts St-40 and SC-1-NU in BALB/c nu/nu mice. The drugs were administered intraperitoneally at doses of 2 or 4 mg/kg for MMC and 3 or 6 mg/kg fo